The stock of Bruker Corp (BRKR) has seen a -0.89% decrease in the past week, with a -11.68% drop in the past month, and a 14.92% flourish in the past quarter. The volatility ratio for the week is 3.74%, and the volatility levels for the past 30 days are at 2.54% for BRKR. The simple moving average for the past 20 days is -6.13% for BRKR’s stock, with a 14.48% simple moving average for the past 200 days.
Is It Worth Investing in Bruker Corp (NASDAQ: BRKR) Right Now?
Bruker Corp (NASDAQ: BRKR) has a higher price-to-earnings ratio of 28.24x compared to its average ratio. BRKR has 36-month beta value of 1.20. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 2 as “overweight,” 10 as “hold,” and 1 as “sell.”
The public float for BRKR is 89.28M, and currently, short sellers hold a 3.72% ratio of that float. The average trading volume of BRKR on April 25, 2024 was 808.91K shares.
BRKR) stock’s latest price update
Bruker Corp (NASDAQ: BRKR) has experienced a decline in its stock price by -0.32 compared to its previous closing price of 82.46. However, the company has seen a fall of -0.89% in its stock price over the last five trading days. GeekWire reported 2024-04-17 that NanoString announced Wednesday that it will be acquired by Bruker, ending the company’s restructuring process that included a Chapter 11 bankruptcy plan.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with JP Morgan repeating the rating for BRKR by listing it as a “Overweight.” The predicted price for BRKR in the upcoming period, according to JP Morgan is $90 based on the research report published on February 14, 2024 of the current year 2024.
Wells Fargo, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $72. The rating they have provided for BRKR stocks is “Equal Weight” according to the report published on December 19th, 2023.
Wolfe Research gave a rating of “Outperform” to BRKR, setting the target price at $80 in the report published on December 13th of the previous year.
BRKR Trading at -6.03% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.35% of loss for the given period.
Volatility was left at 2.54%, however, over the last 30 days, the volatility rate increased by 3.74%, as shares sank -11.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.43% upper at present.
During the last 5 trading sessions, BRKR fell by -0.89%, which changed the moving average for the period of 200-days by +10.77% in comparison to the 20-day moving average, which settled at $87.05. In addition, Bruker Corp saw 11.87% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from Requardt Hermann Fritz, who sale 15,000 shares at the price of $90.06 back on Mar 04 ’24. After this action, Requardt Hermann Fritz now owns 23,147 shares of Bruker Corp, valued at $1,350,898 using the latest closing price.
Busse Falko, the PRESIDENT, BIOSPIN GROUP of Bruker Corp, sale 28,122 shares at $85.48 during a trade that took place back on Feb 28 ’24, which means that Busse Falko is holding 32,859 shares at $2,403,890 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.51 for the gross margin
The net margin for Bruker Corp stands at 0.14. The total capital return value is set at 0.14. Equity return is now at value 34.30, with 10.87 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 0.94. The interest coverage ratio of the stock is -11.98.
Currently, EBITDA for the company is 597.2 million with net debt to EBITDA at 1.55. When we switch over and look at the enterprise to sales, we see a ratio of 4.12. The receivables turnover for the company is 4.77for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
To put it simply, Bruker Corp (BRKR) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
